Literature DB >> 25865558

Severe contact esophagitis in a patient taking crizotinib: A case report.

Ciara Conduit1, Mark Wilson, Karen Hunter, Vince Murdolo, Louise Nott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25865558     DOI： 10.1111/ajco.12341

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN： 1743-7555            Impact factor:   2.601


× No keyword cloud information.
  3 in total

1.  Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review.

Authors:  Patrick Jung; Kyle J Fortinsky; Zane R Gallinger; Piero Tartaro
Journal:  Case Rep Gastrointest Med       Date:  2016-12-08

2.  Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC.

Authors:  Qian Zhu; Hao Hu; Feng Jiang; Chang Ying Guo; Xiong Wen Yang; Xi Liu; Yu Kang Kuang
Journal:  Oncotarget       Date:  2017-06-17

Review 3.  Second- and third-generation ALK inhibitors for non-small cell lung cancer.

Authors:  Jingjing Wu; John Savooji; Delong Liu
Journal:  J Hematol Oncol       Date:  2016-03-08       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.